metformin has been researched along with guanine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, ML; Hofman, A; Stricker, BH; Uitterlinden, AG; van Schaik, RH; Visser, LE | 1 |
Alhaider, AA; Ansari, MA; Denison, MS; El-Kadi, AO; Ghebeh, H; Korashy, HM; Maayah, ZH; Soshilov, AA | 1 |
2 other study(ies) available for metformin and guanine
Article | Year |
---|---|
Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.
Topics: Adenine; Aged; Aged, 80 and over; Bile; Blood Glucose; Cohort Studies; Creatinine; Diabetes Mellitus; Drug Resistance, Multiple; Epithelial Cells; Female; Genetic Variation; Genotype; Glomerular Filtration Rate; Glycated Hemoglobin; Guanine; Hepatocytes; Humans; Kidney; Male; Metformin; Organic Cation Transport Proteins; Polymorphism, Single Nucleotide; White People | 2009 |
Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Breast Neoplasms; Carcinogenesis; Carcinogens; Cell Line, Tumor; Cytochrome P-450 CYP1A1; DNA Adducts; Female; Guanine; Humans; Metformin; Mice; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Signal Transduction | 2015 |